...
首页> 外文期刊>Analytica chimica acta >Ultrasensitive flexible FET-type aptasensor for CA 125 cancer marker detection based on carboxylated multiwalled carbon nanotubes immobilized onto reduced graphene oxide film
【24h】

Ultrasensitive flexible FET-type aptasensor for CA 125 cancer marker detection based on carboxylated multiwalled carbon nanotubes immobilized onto reduced graphene oxide film

机译:超敏感的柔性FET型Aptasensor用于Ca 125癌症标记检测,基于固定在氧化石墨烯膜上的羧化多壁碳纳米管

获取原文
获取原文并翻译 | 示例

摘要

The development of a novel flexible and ultrasensitive aptasensor based on carboxylated multiwalled carbon nanotubes (MWCNTs)/ reduced graphene oxide-based field effect transistor (FET) has been reported for label-free detection of the ovarian cancer antigen (CA125). The fabricated sensor has a straightforward design based on the noncovalent attachment of MWCNTs/aptamer conjugated onto few layers reduced graphene oxide nanosheets and its integration with poly-methyl methacrylate (PMMA) as a suitable platform for designing flexible field-effect transistors. The surface properties of the aptasensor were characterized using scanning electron microscopy (SEM), transmission electron microscopy (TEM) and atomic force microscopy (AFM). Under optimal conditions, the proposed aptasensor exhibited a wide linear dynamic range for CA125 (1.0 x 10 x(-9)-1.0 U/mL) with a low detection limit of 5.0 x 10 x(-10) U/mL. The proposed aptasensor was also successfully applied to detect CA125 in real human serum samples. Furthermore, sensor flexibility is also a challenging area in chemical and biological sensors, especially for portable, wearable, or even implantable sensors, so, the reduced graphene oxide-based FET-type aptasensor showed bendable flexibility on the PMMA substrate. In addition, the aptasensor exhibited high sensitivity, selectivity, stability and reproducibility which offers great promise as a high performance and flexible FET-type aptasensor to detect CA125 and other cancer biomarkers in clinical samples and biological fluids. (c) 2017 Elsevier B.V. All rights reserved.
机译:据报道,基于羧化多壁碳纳米管(MWCNTS)/减少的石墨烯基效应晶体管(FET)的新型柔性和超细氧化物传感器的开发已被报告用于无标记检测卵巢癌抗原(CA125)。制造的传感器具有基于MWCNT / Aptamer的非共价附着在少量的石墨烯氧化物纳米片上的非共价附着的简单设计,以及与聚 - 甲基丙烯酸甲酯(PMMA)的整合为适合设计柔性场效应晶体管的合适平台。使用扫描电子显微镜(SEM),透射电子显微镜(TEM)和原子力显微镜(AFM)表征Aptasensor的表面性质。在最佳条件下,所提出的aptasensor对于Ca125(1.0×10 x(-9)-1.0u / ml)的宽线性动态范围,低检测限为5.0×10 x(-10)U / ml。提出的Aptasensor也被成功地应用于检测真正的人血清样品中的CA125。此外,传感器柔韧性也是化学和生物传感器的具有挑战性的区域,特别是对于便携式,可穿戴甚至可植入的传感器,因此,降低的石墨烯基FET型Aptasensor在PMMA基板上显示了可弯曲的柔韧性。此外,Aptasensor表现出高灵敏度,选择性,稳定性和再现性,其具有高性能和灵活的FET型Aptasensor,以检测临床样品和生物流体中的CA125和其他癌症生物标志物。 (c)2017 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号